Everest Medicines Announces First Drug Approval of Trodelvy® in Singapore for Second-Line Metastatic Triple-Negative Breast Cancer
Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of Trodelvy in Asia. Everest Medicines, a biopharmaceutical company focused on developing and...